BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7624867)

  • 1. Cephaloridine nephrotoxicity in diabetic rats: modulation by insulin treatment.
    Valentovic MA; Ball JG
    Toxicology; 1995 Jun; 100(1-3):11-6. PubMed ID: 7624867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cephaloridine nephrotoxicity in streptozotocin induced diabetic Fischer 344 (F344) rats.
    Valentovic MA; Ball JG; Elliott C; Madan E
    Toxicology; 1989 Jul; 57(2):193-207. PubMed ID: 2749746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of acetone and osmotic-diuresis by streptozotocin-induced diabetes in attenuation of cephaloridine nephrotoxicity.
    Valentovic M; Ball JG; Anestis D
    Toxicology; 1992; 71(3):245-55. PubMed ID: 1736416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats.
    Scott LA; Madan E; Valentovic MA
    Toxicology; 1990; 60(1-2):109-25. PubMed ID: 2107603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of cisplatin nephrotoxicity by streptozotocin-induced diabetes.
    Scott LA; Madan E; Valentovic MA
    Fundam Appl Toxicol; 1989 Apr; 12(3):530-9. PubMed ID: 2731667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-(3,5-dichlorophenyl)succinimide nephrotoxicity in streptozotocin-induced diabetic rats.
    Valentovic MA; Teets VJ; Nicoll D; Stern J; Leppla D; Rankin GO
    Toxicology; 1990 Sep; 63(3):327-39. PubMed ID: 2145659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cephaloridine renal accumulation and urinary excretion between normoglycemic and diabetic animals.
    Valentovic MA; Ball JG; Rogers BA
    Toxicology; 1996 Apr; 108(1-2):93-9. PubMed ID: 8644123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cephaloridine in vitro toxicity and accumulation in renal slices from normoglycemic and diabetic rats.
    Valentovic M; Ball JG; Rogers BA; Meadows MK; Harmon RC; Moles J
    Fundam Appl Toxicol; 1997 Aug; 38(2):184-90. PubMed ID: 9299192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cephaloridine nephrotoxicity in aging male Fischer-344 rats.
    Goldstein RS; Pasino DA; Hook JB
    Toxicology; 1986 Jan; 38(1):43-53. PubMed ID: 3942010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of in vitro renal cephaloridine toxicity between normoglycemic and diabetic rats.
    Valentovic MA; Jeffrey W; Ball JG; Bailly D; Morenas M; Kinder J
    J Appl Toxicol; 1992 Feb; 12(1):19-24. PubMed ID: 1564248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxicity of 4-amino-2-chlorophenol and 2-amino-4-chlorophenol in the Fischer 344 rat.
    Hong SK; Valentovic MA; Anestis DK; Ball JG; Brown PI; Rankin GO
    Toxicology; 1996 Jun; 110(1-3):47-58. PubMed ID: 8658559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cephaloridine nephrotoxicity: strain and sex differences in mice.
    Pasino DA; Miura K; Goldstein RS; Hook JB
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 1):1153-60. PubMed ID: 4092877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxicity of N-(3-bromophenyl)-2-hydroxysuccinimide: role of halogen groups in the nephrotoxic potential of N-(halophenyl) succinimides.
    Hong SK; Anestis DK; Hawco NM; Valentovic MA; Brown PI; Rankin GO
    Toxicology; 1996 Jun; 110(1-3):17-25. PubMed ID: 8658556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo and in vitro 4-amino-2,6-dichlorophenol nephrotoxicity and hepatotoxicity in the Fischer 344 rat.
    Rankin GO; Valentovic MA; Nicoll DW; Ball JG; Anestis DK; Wang RT; Brown PI
    Toxicology; 1994 May; 90(1-2):115-28. PubMed ID: 8023337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset of cisplatin-induced nephrotoxicity in streptozotocin-diabetic rats treated with insulin.
    Sarangarajan R; Cacini W
    Basic Clin Pharmacol Toxicol; 2004 Aug; 95(2):66-71. PubMed ID: 15379782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephaloridine and cephalothin: comparative studies of potential nephrotoxicity.
    Perkins RL; Apicella MA; Lee IS; Cuppage FE; Saslaw S
    J Lab Clin Med; 1968 Jan; 71(1):75-84. PubMed ID: 4965437
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal accumulation and urinary excretion of cisplatin in diabetic rats.
    Valentovic MA; Scott LA; Madan E; Yokel RA
    Toxicology; 1991; 70(2):151-62. PubMed ID: 1763412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions among nephrotoxicants: N-(3,5-dichlorophenyl)succinimide and cephaloridine.
    Rankin GO; Teets VJ; Nicoll DW; Brown PI
    Toxicology; 1991 Feb; 66(1):47-62. PubMed ID: 1996467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on pyrazinoylguanidine. 5. Temporal effects over 24 weeks demonstrating attenuation of diabetic nephropathy in STZ-diabetic rats.
    Follansbee MH; Beyer KH; Griffith JW; Vesell ES
    Pharmacology; 1997 May; 54(5):241-55. PubMed ID: 9380770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of drug-metabolizing enzyme inducers on cephaloridine toxicity in Fischer 344 rats.
    Kuo CH; Hook JB
    Toxicology; 1982; 24(3-4):293-303. PubMed ID: 6100830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.